Abstract:Introduction: Immunogenicity refers to the ability of a substance, such as a therapeutic drug, to elicit an immune response. While beneficial in vaccine development, undesirable immunogenicity can compromise the safety and efficacy of therapeutic proteins by inducing anti-drug antibodies (ADAs). These ADAs can reduce drug bioavailability and alter pharmacokinetics, necessitating comprehensive immunogenicity risk assessments starting at early stages of drug development. Given the complexity of immunogenicity, an integrated approach is essential, as no single assay can universally recapitulate the immune response leading to the formation of anti-drug antibodies. Methods: To better understand the Dendritic Cell (DC) contribution to immunogenicity, we developed two flow cytometry-based assays: the DC internalization assay and the DC activation assay. Monocyte-derived dendritic cells (moDCs) were generated from peripheral blood mononuclear cells (PBMCs) and differentiated over a five-day period. The internalization assay measured the accumulation rate of therapeutic antibodies within moDCs, while the activation assay assessed the expression of DC activation markers such as CD40, CD80, CD86, CD83, and DC-SIGN (CD209). To characterize these two assays further, we used a set of marketed therapeutic antibodies. Results: The study highlights that moDCs differentiated for 5 days from freshly isolated monocytes were more prone to respond to external stimuli. The internalization assay has been shown to be highly sensitive to the molecule tested, allowing the use of only 4 donors to detect small but significant differences. We also demonstrated that therapeutic antibodies were efficiently taken up by moDCs, with a strong correlation with their peptide presentation on MHC-II. On the other hand, by monitoring DC activation through a limited set of activation markers including CD40, CD83, and DC-SIGN, the DC activation assay has the potential to compare a series of compounds. These two assays provide a more comprehensive understanding of DC function in the context of immunogenicity, highlighting the importance of both internalization and activation processes in ADA development. Discussion: The DC internalization and activation assays described here address key gaps in existing immunogenicity assessment methods by providing specific and reliable measures of DC function. The assays enhance our ability to pre-clinically evaluate the immunogenic potential of biotherapeutics, thereby improving their safety and efficacy. Future work should focus on further validating these assays and integrating them into a holistic immunogenicity risk assessment framework.

Functionality and specificity of gene markers for skin sensitization in dendritic cells

In Vitro Dendritic Cell-Based Test for Skin Sensitizers Identification and Potency Estimation

Evaluation of selected biomarkers for the detection of chemical sensitization in human skin: a comparative study applying THP-1, MUTZ-3 and primary dendritic cells in culture

Identification of Candidate Genes in Atopic Dermatitis Based on Bioinformatic Methods

Murine bone marrow-derived dendritic cells as a potential in vitro model for predictive identification of chemical sensitizers

Proteomics analysis of dendritic cell activation by contact allergens reveals possible biomarkers regulated by Nrf2

Signal transduction profile of chemical sensitisers in dendritic cells: An endpoint to be included in a cell-based in vitro alternative approach to hazard identification?

Pathway analysis of gene expression in local lymph nodes draining skin exposed to three different sensitizers

Incorporating immune cell surrogates into a full-thickness tissue equivalent of human skin to characterize dendritic cell activation

A human 3D immune competent full-thickness skin model mimicking dermal dendritic cell activation

In Vitro Monitoring of Human T Cell Responses to Skin Sensitizing Chemicals—A Systematic Review

[In Vitro Evaluation of Cutaneous Allergic Reaction Induced by Chemicals Using Dendritic Cells].

Molecular characterization of allergens and component-resolved diagnosis of IgE-mediated mango fruit allergy

Benchmarking of BMDC assay and related QSAR study for identifying sensitizing chemicals

In vitro detection of contact allergens: development of an optimized protocol using human peripheral blood monocyte-derived dendritic cells

Bridging the Gap Between Tolerogenic Dendritic Cells In Vitro and In Vivo: Analysis of Siglec Genes and Pathways Associated with Immune Modulation and Evasion

Chemical-Specific T Cell Tests Aim to Bridge a Gap in Skin Sensitization Evaluation

Development and characterization of dendritic cell internalization and activation assays contributing to the immunogenicity risk evaluation of biotherapeutics

The transcriptomic signature of respiratory sensitizers using an alveolar model

Gene profiling in active dermatitis lesions strengthens the diagnosis of allergic contact dermatitis

Membrane Surface Molecules Expression on Mice Dendritic Cells Derived from Bone Arrow Induced by 2,4-Dinitrochlorobenzene